News

Our Cardiac BioSimulator has once again played a crucial role in a recent publication. This publication outlines an ex vivo cardiac study conducted to examine the potential of intravalvular impedance (IVI) measurements in a sensorized biological heart valve prosthesis.

We had a great training and team building day together with Rachael Raskovich from Resolution Medical.

We are thrilled to announce that João, a talented and passionate researcher, has joined our team at LifeTec Group! Discover more about his incredible journey and how he has become a very valuable asset to our organization.

As part of the RegMed XB project, LifeTec Group is working with the University Medical Center in Utrecht to develop regenerative technologies for repairing failing human hearts.

We will be showcasing our Cardiac BioSimulator at EuroPCR 2023, a major event in interventional cardiovascular medicine taking place in Paris from May 16th to 19th. Meet us at booth M37 to learn more about our innovative technologies and connect with our team.

Today is World Day for Laboratory Animals, a day to recognize the importance of treating animals humanely in scientific research. At LifeTec Group, we are committed to minimizing potential suffering of laboratory animals with the use of our biosimulators, while providing meaningful, safe, and reliable medical solutions.

The Cardiac Biosimulator is set to become even more realistic through the INNOCHORD project. By partnering with CoreMedic, we will improve vascular access, interaction with imaging modalities, and automate heart response.

We're teaming up with Cardiac Dimensions to showcase their Carillon Mitral Contour System® using our Cardiac BioSimulator at the German Cardiology Conference DGK. Join us in Mannheim from April 12th to 14th at Cardiac Dimensions Booth 140 to see it in action!

LifeTec Group is working on prototyping capabilities in Eindhoven thanks to a merger with Resolution Medical. This will speed up the development and evaluation of medical devices.